Benzonatate
Other Cough Suppressants
- Drug class
- Other Cough Suppressants
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 9
- FDA reports (12 mo)
- 1,441
Overview
Plain-language summary, compiled from the cited regulatory records
Benzonatate is an antitussive medication [1]. It belongs to the drug class of other cough suppressants [1]. Benzonatate is approved for the symptomatic relief of cough [1].
This medication is available under various brand names [1]. In the past 12 months, there have been 1441 adverse event reports associated with benzonatate [2]. The most frequently reported adverse events include cough, intentional product use issues, diarrhea, nausea, and dyspnea [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 9 | April 7, 2026 |
USUnited States· FDA
9 products
Uses
INDICATIONS AND USAGE
Benzonatate Capsule is indicated for the symptomatic relief of cough.
How to take
Drug interactions
Known interactions involving Benzonatate. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 07018b47-76f5-49… · revised February 2, 2026 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.